Equities research analysts at StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a research report issued to clients and investors on Wednesday. The firm set a “sell” rating on the stock.
Ampio Pharmaceuticals Price Performance
NYSE AMPE opened at $0.00 on Wednesday. The firm’s 50 day moving average is $0.01 and its 200-day moving average is $0.03. Ampio Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $2.91. The company has a market capitalization of $2,951.00, a PE ratio of 0.00 and a beta of 3.67.
Ampio Pharmaceuticals Company Profile
Recommended Stories
- Five stocks we like better than Ampio Pharmaceuticals
- 3 Ways To Invest In Coffee, Other Than Drinking It
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- There Are Different Types of Stock To Invest In
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- Ride Out The Recession With These Dividend Kings
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
